Stimulation of ABL2 Tyrosine Kinase Activity by RIN1 no effect on RIN1 phosphorylation or binding (Figure 2C) .
To determine whether RIN1 could influence the catalytic activity of ABL proteins, we examined cellular tyroWe confirmed the requirement for RIN1 tyrosine phosphorylation in ABL2 binding through the use of a sine-phosphorylation levels. dence that RIN1 alters the catalytic properties of ABL2, ABL2 was expressed with RIN1 or with RIN1-ABD (Figure 4D ). An increase in tyrosine-phosphorylated CRKL at least in part, independently of this phosphoactivation.
was also noted in the sample that received only RIN1-ABD (compare lanes 1 and 6), reflecting stimulation of Because all of the elements required for ABL binding reside in the ABD region of RIN1 (residues 1-295), we endogenous ABL proteins. To determine whether RIN1 is a physiological regulatested whether this domain alone could stimulate tyrosine kinase activity. Indeed, we detected strong stimutor of CRKL phosphorylation, we analyzed mouse forebrain tissue, where RIN1 is expressed at highest levels lation of ABL2-mediated cellular phosphotyrosine by the ABD fragment of RIN1 ( Figure 4B (Figure 5C) . The inhibitory effect of STI571 confirmed that the assay was detecting primarily ABL kinase activity ( Figure 5C ). These results suggest that ABL stimulation is an intrinsic property of RIN1, at least with regard to the CRK substrate. Cellular factors may participate in vivo to further modulate these effects.
RAS-RIN1-ABL2: A Signal-Transduction Pathway
We examined whether RIN1, a known RAS effector, can function as a physical conduit for signal transduction from RAS to ABL proteins. Expression of HRAS G12V (activated RAS), RIN1, and ABL2 resulted in the formation of a complex including all three proteins, as detected by immunoprecipitation of either ABL2 or HRAS ( Figure  6A ). In each case, the association of HRAS with ABL2 was dependent on the presence of RIN1. The formation of this stable complex is consistent with a pathway connecting RAS proteins with the cytoplasmic functions of ABL-family tyrosine kinases through RIN1.
The RIN1-ABD fragment appeared to be more potent 
MECs migrated toward hepatocyte growth factor (HGF)
A Novel ABL Activation Pathway RIN1 binding stimulates ABL2 activity, providing the at a higher rate than did wild-type MECs ( Figure 7C) . To confirm the role of RIN1 in regulating cell migration, only example of an ABL kinase activator that can function in a purified-protein system. RIN1 may activate we employed small interfering RNA (siRNA) to knock down RIN1 expression 10-fold in the human mammary ABL2 by inducing a conformational change that increases catalytic activity; binding to both the SH3 and epithelial-cell line MCF10A ( Figure 7D) . A negative-control siRNA at the same concentration had no effect SH2 domains of ABL would be predicted to relieve autoinhibitory aspects of the inactive ABL structure [6, (data not shown). RIN1 siRNA reduced CRKL phosphorylation levels ( Figure 7D ) and blocked CRKL phos-17]. This is consistent with the ability of RIN1 to rescue 
